Nurix Therapeutics Inc’s filing revealed that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.25 million on Aug 26 ’24. In the deal valued at $25.01 per share,9,870 shares were sold. As a result of this transaction, Ring Christine now holds 24,592 shares worth roughly $0.62 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, van Houte Hans sold 20,000 shares, generating $504,370 in total proceeds. Upon selling the shares at $25.22, the Chief Financial Officer now owns 31,002 shares.
Before that, JOHANNES VAN HOUTE bought 20,000 shares. Nurix Therapeutics Inc shares valued at $480,400 were divested by the Officer at a price of $24.02 per share.
Truist initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on July 31, 2024; the price target was $36. Barclays began covering NRIX with “an Overweight” recommendation on March 09, 2023. Oppenheimer started covering the stock on February 28, 2023. It rated NRIX as “an Outperform”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock jump 0.80% to $25.20. Over the last five days, the stock has gained 4.91%. Nurix Therapeutics Inc shares have risen nearly 144.19% since the year began. Nevertheless, the stocks have risen 193.36% over the past one year. While a 52-week high of $26.12 was reached on 08/26/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $21.83, while 200 days put it at $14.28.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 24.56, which if violated will result in even more drops to 23.92. On the upside, there is a resistance level at 25.71. A further resistance level may holdings at 26.22. The Relative Strength Index (RSI) on the 14-day chart is 64.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.40, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 18.01%. Stochastics %K at 82.15% indicates the stock is a selling.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-08-15, growing by 0.4 million shares to a total of 9.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 8.84 million shares. There was a rise of 4.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2022 when Morgan Stanley began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $11 price target.
